Navigation Links
New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia

ation of SEROQUEL was administered twice-daily and escalated from 50 mg/day to 400 mg/day over a five-day period. The most common adverse events seen in the active treatment groups during the trial were somnolence and dizziness. The incidences of adverse events leading to discontinuation were low: 5.3%, 2.7%, and 2.5% in the SEROQUEL XR 400, 600, 800 mg/day groups; 4.9% in the immediate release SEROQUEL group; and 2.5% in the placebo group. Individual extrapyramidal symptoms (EPS)-related adverse events occurred in three patients or less in all treatment groups.(1,2)

    (+) Schizophrenic symptomatology measured on 30-item Positive and Negative

        Syndrome Scale (PANSS) scale. Each symptom was rated on a severity

        scale from 1-7. PANSS positive (7 items), negative (7 items), and

        general psychopathology (16 items) subscale scores were summarized to

        give the PANSS total score.(3)

About a poster presentation entitled: Efficacy of Once-Daily Extended Release

Quetiapine Fumarate in Patients with Acute Schizophrenia

This first analysis of Study 132 evaluated the efficacy of SEROQUEL XR versus placebo in patients with schizophrenia. The primary endpoint was the change from baseline to Day 42 in PANSS total score.(1)

After six weeks, the mean PANSS total score decreased significantly with SEROQUEL XR (400 mg: -24.8, p < 0.05; 600 mg: -30.9, p < 0.001; 800 mg: -31.3, p < 0.001) compared with placebo (-18.8). In addition, PANSS response rates for SEROQUEL XR (all doses) were significantly higher than for placebo (p < 0.05).(1)

About a poster presentation entitled: Efficacy of Once-Daily Extended Release

Quetiapine Fumarate across Symptom Domains in Schizophrenia

In this second analysis of Study 132, the efficacy of SEROQUEL XR was evaluated across a broad range of symptoms in schizophrenia, including positive and negative symptoms as well as symptoms of general psychopathology, aggr
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:7/31/2015)... -- The Physician-Patient Alliance for Health & Safety ... "Surviving Your Hospital Stay: Physician-Patient Alliance for Health ... A sentence was omitted from the release. ... is a member of the National Coalition to Promote ... the National Coalition to Promote Continuous Monitoring of Patients ...
(Date:7/31/2015)... , July 31, 2015 Egalet ... integrated specialty pharmaceutical company focused on developing, manufacturing ... closing of its previously announced underwritten public offering ... a public offering price of $11.25 per share. ... included 1,000,000 shares issued upon the exercise in ...
(Date:7/31/2015)... 31, 2015 Magnaquest, a ... data and cloud computing operators has signed a ... giant for Internet of Things (IoT) related initiative. ... on subscription model.      (Logo: ... striving for business innovations to make healthcare services ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... 1 The Center for,Translational Molecular Medicine (CTMM) ... and development of new techniques for,the diagnosis and ... nine,projects will receive research funding amounting to a ... a broad spectrum of small and,medium-sized enterprises, major ...
... warmer,the American Heartworm Society (AHS) wants every pet owner ... risk it carries for pets., Although the risk ... mosquito population increases, the AHS recommends year-round,prevention for both ... pet owners will have their pets protected when they ...
Cached Medicine Technology:Dutch Top Institute Allocates 150 Million Euro to R&D Projects Targeting Early Diagnosis and Treatment of Disease 2Mosquito Season Approaching: American Heartworm Society Reminds Pet Owners of Risk 2
(Date:7/31/2015)... Atlanta, GA (PRWEB) , ... July 31, 2015 ... ... Medicine Practice, Pediatric Emergency Medicine Practice, and Hospital Medicine Practice, is pleased to ... Practice in a mobile application format available on iPhones, iPads, and Android ...
(Date:7/31/2015)... ... 31, 2015 , ... A family-run business in Grand Rapids, ... sourced all over the world, then manufactured into specific formulations in northern Michigan. ... highest-quality oils in the industry, which we are bringing to consumers at prices ...
(Date:7/31/2015)... ... July 31, 2015 , ... An ... from NBC talked about a woman’s unfortunate experience having cosmetic skin procedures done ... face, which resulted in blistering, swelling, bruising, and pain. This woman’s experience is ...
(Date:7/31/2015)... ... ... Super-Sod wants to participate in planning new home lawns from the ground ... fit for such a goal. Houzz is a social media site that features home ... that spreads home and home garden design ideas when members share their project pictures ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... distribution of a wide variety of nutritional and wellness products, announced the addition ... that specializes in massage therapy, active isolated stretching and the prevention and rehabilitation ...
Breaking Medicine News(10 mins):Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2
... Beneficiaries enrolled in Medicare Part D who reached a ... hole" were much less likely to use prescription drugs ... University of Pittsburgh Graduate School of Public Health study. ... of Health Affairs , raise concerns about health ...
... 2, 2009) New research published in the February issue ... shows a warm-up of 15 to 20 minutes with ... substantial increase in proficiency of surgical skills in surgeons of ... both psychomotor and cognitive skills raises surgeons, alertness to a ...
... at Health Budget HearingALBANY, N.Y., Feb. 2 Today, ... Hearing to address three major issues that impact the ... aging New Yorkers: prescription drug access and affordability, ... care."These issues are critical to New Yorkers staying healthy ...
... NEW YORK, Feb. 2 Weight Watchers International, Inc. (NYSE: ... fourth quarter and full year 2008 after the NYSE close ... conference call on March 4th at 5:00 p.m. ET. During ... and Ann Sardini, Chief Financial Officer, will discuss fourth quarter ...
... HOLLAND, Mich., Feb. 2 Hudsonville Ice Cream today,voluntarily ... Whirl Ice Cream,(UPC# 70438 10250 8), which is available ... Market, L&L Food centers and others. , ... that contain nuts that were,processed in the Blakeley, Ga. ...
... 2 /PRNewswire/ -- Kirby Lester, LLC, the ... fully automated technology breakthrough: the KL30 automated dispensing ... is sized and priced for any retail pharmacy or ... prescriptions per day.Kirby Lester introduced the KL30 today at ...
Cached Medicine News:Health News:Seniors in Medicare's doughnut hole decrease use of meds 2Health News:Journal of American College of Surgeons study finds warm-up helps surgeons improve performance 2Health News:AARP Urges Governor to Use Budget to Maintain Quality of Life For Aging New Yorkers 2Health News:AARP Urges Governor to Use Budget to Maintain Quality of Life For Aging New Yorkers 3Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Earnings Conference Call 2Health News:Kirby Lester's New KL30: Fully Automated, Compact System for a Fraction of the Cost of a Robotic Dispenser 2Health News:Kirby Lester's New KL30: Fully Automated, Compact System for a Fraction of the Cost of a Robotic Dispenser 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: